Age and lack of β-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarction-Reference-Cited by-同舟云学术

Age and lack of β-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarction

Published:2003-03 Issue:1 Volume:88 Page:63-68
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Juliard Jean-Michel,Charlier Patrick,Golmard Jean-Louis,Himbert Dominique,Aubry Pierre,Benamer Hakim,Feldman Laurent J.,Karila-Cohen Daniel,Steg Ph.Gabriel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction;Hartzler;Am Heart J,1983

2. Emergency percutaneous transluminal coronary angioplasty without thrombolysis as initial therapy in acute myocardial infarction;Marco;Int J Cardiol,1987

3. Long-term follow-up of patients treated with coronary angioplasty for acute myocardial infarction;Kander;Am Heart J,1989

4. Late outcome after percutaneous transluminal coronary angioplasty during acute myocardial infarction;O’Murchu;Am J Cardiol,1993

5. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow-up of 18 months;Zijlstra;Coronary Artery Dis,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-Blockers in Asymptomatic Coronary Artery Disease;Journal of the American College of Cardiology;2014-07

2. New-onset atrial fibrillation and prognosis in nonagenarians after acute myocardial infarction;Netherlands Heart Journal;2013-07-03

3. Adjunctive Pharmacologic Therapies;Clinical Guide to Primary Angioplasty;2010-05-21

4. A critical appraisal of current models of risk stratification for percutaneous coronary interventions;American Heart Journal;2005-05

5. Utility of Intravenous β-Blocker Administration in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Intervention;Heart Drug;2005